首站-论文投稿智能助手
典型文献
Bile reflux and bile acids in the progression of gastric intestinal metaplasia
文献摘要:
Gastric intestinal metaplasia (GIM) is a precancerous lesion of gastric cancer (GC) and is considered an irreversible point of progression for GC. Helicobacter pylori infection can cause GIM, but its eradication still does not reverse the process. Bile reflux is also a pathogenic factor in GIM and can continuously irritate the gastric mucosa, and bile acids in refluxed fluid have been widely reported to be associated with GIM. This paper reviews in detail the relationship between bile reflux and GIM and the mechanisms by which bile acids induce GIM.
文献关键词:
Bile acids;Bile reflux;Farnesoid X receptor;Gastric intestinal metaplasia;Hepatocyte nuclear factor 4α;Methylation;Nuclear factor-κB
作者姓名:
Qu Xiaodong;Shi Yongquan
作者机构:
State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases, Xijing Hospital, Air Force Medical University, Xi’an, Shaanxi 710032, China
引用格式:
[1]Qu Xiaodong;Shi Yongquan-.Bile reflux and bile acids in the progression of gastric intestinal metaplasia)[J].中华医学杂志(英文版),2022(14):1664-1672
A类:
irritate,refluxed
B类:
Bile,bile,acids,progression,gastric,intestinal,metaplasia,Gastric,GIM,precancerous,lesion,considered,irreversible,point,Helicobacter,pylori,infection,cause,but,its,eradication,still,does,not,reverse,process,also,pathogenic,continuously,mucosa,fluid,have,been,widely,reported,associated,This,paper,reviews,detail,relationship,between,mechanisms,by,which,induce,Farnesoid,receptor,Hepatocyte,nuclear,Methylation,Nuclear
AB值:
0.494402
相似文献
Chinese clinical practice guidelines for ultrasound-guided irreversible electroporation of liver cancer(version 2022)
Min Xu;Li-Ting Xie;Yue-Yong Xiao;Ping Liang;Qi-Yu Zhao;Zhong-Min Wang;Wei-Lu Chai;Ying-Tian Wei;Lin-Feng Xu;Xiao-Kun Hu;Ming Kuang;Li-Zhi Niu;Chen-Guo Yao;Hai-Ying Kong;Guo Tian;Xiao-Yan Xie;Xin-Wu Cui;Dong Xu;Jun Zhao;Tian-An Jiang;The Interventional Diagnosis and Treatment Group of the Ultrasonic Medicine Branch of Chinese Medical Association;The Nanoknife Tumor Ablation Society of the Interventional Minimally Invasive Therapy Special Committee of China Medicine Education Association-Department of Ultrasound Medicine,First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Key Laboratory of Pulsed Power Translational Medicine of Zhejiang Province,Hangzhou,Zhejiang 310003,China;Department of Radiology,The First Medical Center,Chinese PLA General Hospital,Beijing 100000,China;Department of Radiology,The Fifth Medical Center,Chinese PLA General Hospital,Beijing 100853,China;Department of Interventional Radiology,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Department of Interventional Radiology,Sun Yat-Sen Memorial Hospital,Sun Yat-Sen University,Guangzhou 510120,China;Department of the Interventional Medical Center,the Affiliated Hospital of Qingdao University,Qingdao 266000,China;Division of Interventional Ultrasound,The First Affiliated Hospital of Sun Yat-Sen University,Guangzhou 510080,China;Department of Oncology,Affiliated Fuda Cancer Hospital,Jinan University,Guangzhou 510665,China;School of Electrical Engineering,Chongqing University,Chongqing 400033,China;Department of Anesthesiology,First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Department of Medical Ultrasonics,Institute of Diagnostic and Interventional Ultrasound,The First Affiliated Hospital of Sun Yat-Sen University,Guangzhou 510080,China;Department of Medical Ultrasound,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Interventional Ultrasound,The Cancer Hospital of the University of Chinese Academy of Sciences(Zhejiang Cancer Hospital),Institute of Basic Medicine and Cancer(IBMC),Chinese Academy of Sciences,Hangzhou 310022,China;Department of Anatomy,School of Basic Medicine,Huazhong University of Science and Technology,Wuhan 430030,China
Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway
Yi-kuan Wu;Zheng-nan Ren;Sheng-long Zhu;Yun-zhou Wu;Gang Wang;Hao Zhang;Wei Chen;Zhao He;Xian-long Ye;Qi-xiao Zhai-State Key Laboratory of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Medicine,Jiangnan University,Wuxi 214122,China;College of Life Science,Northeast Agricultural University,Harbin 150038,China;National Engineering Research Center for Functional Food,Jiangnan University,Wuxi 214122,China;Shandong Key Laboratory of Endocrinology and Lipid Metabolism,Jinan 250021,China;School of Medicine,Shandong University,Jinan 250012,China;Ganjiang Chinese Medicine Innovation Center,Nanchang 330000,China
Transcription factor Klf9 controls bile acid reabsorption and enterohepatic circulation in mice via promoting intestinal Asbt expression
Shuang Liu;Man Liu;Meng-lin Zhang;Cui-zhe Wang;Yin-liang Zhang;Yu-jie Zhang;Chun-yuan Du;Su-fang Sheng;Wei Wang;Ya-tong Fan;Jia-ni Song;Jin-can Huang;Yue-yao Feng;Wei Qiao;Jin-long Huang;Yu-hui Li;Lu Zhou;Jun Zhang;Yong-sheng Chang-Key Laboratory of Immune Microenvironment and Disease(Ministry of Education),Tianjin Key Laboratory of Cellular Homeostasis and Disease,Department of Physiology and Pathophysiology,Tianjin Medical University,Tianjin 300052,China;Department of Basic Medicine,Shihezi University School of Medicine,Shihezi 832000,China;Key Laboratory of Biotechnology of Hubei Province,Key Laboratory of Biotechnology of Chinese Traditional Medicine,National&Local Joint Engineering Research Center of High-throughput Drug Screening Technology,Hubei University,Wuhan 430062,China;Department of Gastroenterology and Hepatology,Tianjin Medical University General Hospital,Tianjin 300052,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。